Author:
Belluomini Lorenzo,Cesta Incani Ursula,Smimmo Annafrancesca,Avancini Alice,Sposito Marco,Insolda Jessica,Mariangela Scaglione Ilaria,Gattazzo Federica,Caligola Simone,Adamo Annalisa,Conciatori Fabiana,Bazzichetto Chiara,Ugel Stefano,Giannarelli Diana,Pilotto Sara,Milella Michele
Reference40 articles.
1. Cancer statistics, 2024;Siegel;CA Cancer J Clin.,2024
2. Marei HE, Hasan A, Pozzoli G, Cenciarelli C. Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired. Cancer Cell Int. Apr 10 2023;23(1):64. doi:10.1186/s12935-023-02902-0.
3. Acquired resistance mechanisms to osimertinib: The constant battle;Zalaquett;Cancer Treat Rev.,2023
4. Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer;Suwinski;BMC Cancer.,2019
5. Wu T, Yang W, Sun A, Wei Z, Lin Q. The Role of CXC Chemokines in Cancer Progression. Cancers (Basel). Dec 28 2022;15(1)doi:10.3390/cancers15010167.